The CRISPR-Cas gene editing tool has shown promising potential in the field of blood compatibility, offering a solution to the challenges faced by patients with rare blood types and addressing chronic ...

Blood compatibility is determined by antigens present on the surface of red blood cells. While the ABO and Rh blood group systems are well-known, with eight primary blood types, there are at least 45 ...

NKure Therapeutics & CRISPR Therapeutics partner to advance CTX112 for cancer treatment in India: Our Bureau, Bengaluru Wednesday, May 7, 2025, 13:45 Hrs [IST] NKure Therapeutics, ...

Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...

The US Food and Drug Administration has given the green light to gene-edited pigs for human consumption. PIC, a UK livestock ...

Genetic modification process has faced criticism, with many agriculturists and scientists raising concerns over its health, ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

These new varieties, developed using CRISPR-Cas genome-editing technology, enable precise genetic alterations without the ...

The findings, published in The Lancet Oncology, hint at a new frontier in the fight against some of the deadliest forms of ...